MDWD
Mediwound LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$181.09M
P/E Ratio
—
EPS
$-2.26
Beta
0.15
52W High
$21.25
52W Low
$13.54
50-Day MA
$16.23
200-Day MA
$17.37
Dividend Yield
—
Profit Margin
-180.30%
Forward P/E
34.97
PEG Ratio
-0.07
About Mediwound Ltd
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Fundamentals
| Revenue (TTM) | $14.48M |
| Gross Profit (TTM) | $2.84M |
| EBITDA | $-27.02M |
| Operating Margin | -541.00% |
| Return on Equity | -71.80% |
| Return on Assets | -23.50% |
| Revenue/Share (TTM) | $1.22 |
| Book Value | $3.22 |
| Price-to-Book | 4.37 |
| Price-to-Sales (TTM) | 12.51 |
| EV/Revenue | 9.98 |
| EV/EBITDA | -6.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -62.70% |
| Shares Outstanding | $12.85M |
| Float | $8.91M |
| % Insiders | 15.86% |
| % Institutions | 58.24% |
Historical Volatility
HV 10-Day
39.86%
HV 20-Day
62.16%
HV 30-Day
54.91%
HV 60-Day
49.01%
HV Rank
97.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($30.17 target)
1
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026